Correlation Use Drugs For Heartburn And The Percentage Of Birth Defects Of Children

Correlation Use Drugs For Heartburn And The Percentage Of Birth Defects Of Children.
Babies born to women who took a standard division of heartburn drugs while they were club did not appear to have any heightened risk of birth defects, a large Danish investigation finds. This class of drugs, known as proton-pump inhibitors (PPIs), include blockbusters such as Prilosec (omeprazole), Prevacid (lansoprazole) and Nexium (esomeprazole). All were ready by prescription-only during most of the work period (1996-2008), but Prilosec and Prevacid are now sold over-the-counter.

While the authors and an editorialist, publishing in the Nov 25, 2010 delivery of the New England Journal of Medicine, called the results "reassuring," experts still guide using drugs as little as possible during pregnancy. "In general, these are probably out of harm's way but it takes a lot of time and a lot of exposures before you see some of the abnormalities that might exist," explained Dr Eva Pressman, professor of obstetrics and gynecology and big cheese of maternal-fetal medicine at the University of Rochester Medical Center. "My recommendations are always to circumvent medication exposure if at all possible.

There are very few life-threatening disorders that require these PPIs. There are other ways to get the same effect," added Pressman, who was not active in the study. "Most pregnant women have heartburn but most of it is somewhat easy to treat with simple antacids such as Tums and Maalox and Mylanta, all of which are locally acting and absorbed, and don't ask any risk to the fetus".

Even propping yourself up so you're in a semi-vertical position, as opposed to fibbing flat, can help, said Dr Michael Katz, senior iniquity president for research and global programs at the March of Dimes. The research was funded by the Danish Medical Research Council and the Lundbeck Foundation.

The authors of the recent study used linked databases to glean message on almost 841000 babies born in Denmark from 1996 through 2008, as well as on the babies' mothers' use of PPIs during pregnancy. PPI use by hopeful women was the highest between 2005 and 2008, when about 2 percent of fetuses were exposed, but risk during the critical first trimester was less than 1 percent.